Douglas Baum
Director/Miembro de la Junta en Regent GLSC Technologies, Inc. .
Fortuna: 5 534 $ al 30/04/2024
Relaciones activas
| Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
|---|---|---|---|---|
| David Arthur Nelson | M | 76 |
Regent GLSC Technologies, Inc.
 Regent GLSC Technologies, Inc. Medical SpecialtiesHealth Technology Part of Regent Technologies, Inc., Regent GLSC Technologies, Inc. is a company that manufactures medical equipment. The company is based in Dallas, TX. David Arthur Nelson has been the CEO of the company since 2007. | 17 años |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
| Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
|---|---|---|---|---|
| Christopher Nelson | M | 54 | 20 años | |
| Steven Pieper | M | 47 |
Xeris Pharmaceuticals, Inc.
 Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | - |
| Kevin M. Bolin | M | 60 | 4 años | |
| Namrata Chand | F | 43 | - | |
| Paul Edick | M | 67 |
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | - |
| Adriann Sax | F | 63 | 2 años | |
| Adam King | M | 39 | 3 años | |
| Scott W. Whitney | M | 67 | 5 años | |
| Tristan Anthony Peitz | M | 40 | 3 años | |
| Jeffrey Soinski | M | 61 | - | |
| C. Piazza | M | 77 | 20 años | |
| Joel D. Mayersohn | M | 66 | 8 años | |
| Jonathan Rigby | M | 56 |
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | 3 años |
| Charles Link | M | 64 | 3 años | |
| Michelle Murcia | F | 56 | 3 años | |
| Arthur W. Batson | M | 64 | - | |
| David Shields | M | - | - | |
| Sudheer M. Pimputkar | M | 74 | 1 años | |
| Christopher J. Spencer | M | 55 | 2 años |
Estadísticas
| País | Relaciones | % del total |
|---|---|---|
| Estados Unidos | 20 | 100.00% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Douglas Baum
- Red Personal
